gip/glp-1 receptor agonist New strategies for the treatment of obesity and metabolic dysfunctions Frontiers | The evolution of

& Derkinderen, P

10.1186/s13287-017-0694-z Summary Keywords GLP-1, GLP-1RAs, T2DM, glucose, mechanism Citation He X, Zhao W, Li P, Zhang Y, Li G, Su H, Lu B and Pang Z (2025) Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus

Individual Results Vary Your results with semaglutide may differ from others

* Correspondence: Gilda Sandri, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Growth in personalized medicine approaches The upsurge in personalized medicine approaches is making a bunch of very real opportunities within the global market for GLP-1 agonists